- You are here:
-
HNRP Home
-
Research
-
Current Research Projects - Blog Style
- HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-targeted HAART
Main Menu
Quick Links
Spotlight
Welcome to the HNRP
HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-targeted HAART
Agency: NIH/NIMH
Agency Award Number: 5R01MH058076-13
To evaluate the efficacy of a CNS-targeted antiretroviral treatment (ART) strategy for individuals with HIV-associated neurocognitive impairment (HNCI) through a randomized clinical trial.
News
- HNRP Investigators presented at the 2024 CROI Conference
- HNRP investigators and trainees presented at the 2024 INS
- David Moore, PhD - Let’s Kick ASS (AIDS Survivor Syndrome) Palm Springs
- 2023 Trainee Champion of Diversity Award winner, Dafna Paltin
- Congratulations to David Grelotti, MD - Top Ranked Physician
- HNRP Investigators presented at 2023 CROI
- HNRP investigators and trainees presented at the 2023 INS
- Congratulations to Dr. Mariana Cherner - Faculty co-Director for the FMTP
- Investigator Spotlight - Jessica Montoya, PhD
- Lily Kamalyan 2022 Trainee Champion of Diversity!
- 2021-2022 JDP Award Winners Vanessa Serrano and Maulika Kohli
- Dr. Grant celebrates Wei-Ming Watson’s receiving her Ph.D. in Clinical Psychology at UC San Diego’s commencement on 6/11/22
Conference Presentations & Media
-
16th Residential Course on Clinical Pharmacology of Antiretrovirals
Scott Letendre, MD, Co-PI, UC San Diego, HNRP Investigator
Read more ... -
Mitochondrial alteration in HIV- and ART- associated neurotoxicity
Read more ...